| Metric | Q2 2026 | Q1 2026 | Q2 2025 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $290M | — | $229M | — | 26.6% |
| Op. Income | $133M | — | $71M | — | 86.6% |
| Gross Margin | 48.2% | — | 33.7% | — | 14.5pp |
| Net Margin | 38.1% | — | 25.5% | — | 12.6pp |
| EPS (Diluted) | $12.79 | — | $6.77 | — | 89.0% |
| Free Cash Flow | $38M | — | $20M | — | 86.8% |
| Item | Amount |
|---|---|
| REVENUE | $290M |
| Cost of Revenue | $151M |
| GROSS PROFIT | $140M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $7M |
| Other Expenses | $0 |
| Operating Expenses | $7M |
| Cost & Expenses | $158M |
| OPERATING INCOME | $133M |
| Interest Income | $7M |
| Interest Expense | $321.9K |
| Other Income/Expenses | $6M |
| INCOME BEFORE TAX | $139M |
| Income Tax Expense | $28M |
| Net Income from Continuing Ops | $111M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $111M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $111M |
| D&A | $15M |
| EBIT | $133M |
| EBITDA | $148M |
| EPS | $13 |
| EPS Diluted | $13 |
| Item | Amount |
|---|---|
| REVENUE | $290M |
| Cost of Revenue | $151M |
| GROSS PROFIT | $140M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $7M |
| Other Expenses | $0 |
| Operating Expenses | $7M |
| Cost & Expenses | $158M |
| OPERATING INCOME | $133M |
| Interest Income | $7M |
| Interest Expense | $321.9K |
| Other Income/Expenses | $6M |
| INCOME BEFORE TAX | $139M |
| Income Tax Expense | $28M |
| Net Income from Continuing Ops | $111M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $111M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $111M |
| D&A | $15M |
| EBIT | $133M |
| EBITDA | $148M |
| EPS | $13 |
| EPS Diluted | $13 |
| Item | Amount |
|---|---|
| Net Income | $111M |
| Depreciation & Amortization | $15M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $28M |
| Other Non-Cash Items | -$13M |
| Change in Working Capital | -$9M |
| OPERATING CASH FLOW | $133M |
| Capital Expenditure | -$95M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $8M |
| NET CASH FROM INVESTING | -$87M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$20M |
| Other Financing Activities | -$1M |
| NET CASH FROM FINANCING | -$21M |
| FREE CASH FLOW | $38M |
| Net Change in Cash | $31M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $105M |
| Short-Term Investments | $0 |
| Net Receivables | $43M |
| Inventory | $31M |
| Other Current Assets | $1 |
| TOTAL CURRENT ASSETS | $178M |
| PP&E (Net) | $605M |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $93M |
| Tax Assets | $4M |
| Other Non-Current Assets | $4M |
| TOTAL NON-CURRENT ASSETS | $705M |
| TOTAL ASSETS | $883M |
| Account Payables | $56M |
| Short-Term Debt | $367.8K |
| Deferred Revenue | $0 |
| Other Current Liabilities | $1 |
| TOTAL CURRENT LIABILITIES | $59M |
| Long-Term Debt | $464.2K |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $137M |
| Other Non-Current Liabilities | $37M |
| TOTAL NON-CURRENT LIABILITIES | $175M |
| TOTAL LIABILITIES | $234M |
| Common Stock | $0 |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $0 |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $649M |
| TOTAL STOCKHOLDERS' EQUITY | $649M |
| Minority Interest | $0 |
| TOTAL EQUITY | $649M |
| TOTAL LIABILITIES & EQUITY | $883M |
| Total Debt | $1M |
| Net Debt | -$103M |
